Just a reminder! If we look at another comparable company and timeline, Algernon, submitted an FDA IND for covid on May 29th and was given the go ahead from the FDA on June 4th. That was only for a Phase 2 study and Algernon is a much smaller company with a lower SP.
If we can expect the same from Revive, then this week we could be off to the FDA Phase 3 races.